Feature | June 23, 2010

The Benefits of Transradial Access

Radial access is very popular outside the United States because it offers improved safety, comfort and cost savings over femoral access, which is the current U.S. standard of care. Femoral access site recovery usually involves heavy, uncomfortable compression of the leg. Patients are also required to lay on their back, in bed and not move for hours to ensure proper hemostasis. These discomforts are eliminated with radial access.

Most importantly, the risk of bleeding and arterial damage, the most common complications following these procedures, is essentially eliminated with the transradial approach, said Jack P. Chen, M.D., FACC, FSCAI, FCCP, director of cardiac research, St. Joseph’s Translational Research Institute, Saint Joseph’s Heart and Vascular Institute, Atlanta. He also directs a course to train cardiologists on the transradial technique.

“If you talk to any patient who has gone through a transfemoral procedure, they will tell you the worst thing is after the procedure. That’s what patients dread the most,” Chen told Diagnostic and Invasive Cardiology. “Most patients complain of the bed rest, the back pain, muscle spasms and the tremendous amount of pressure applied to their groin by a clamp or a staff member. You can spend three hours performing a complex, multidevice, multivessel bifurcation rotablator/stent case with an excellent result, but what the patient will remember is the pain from the pseudoaneurysm repair they now need.”
Radial access eliminates this vascular access risk, as well as the pain and discomfort associated with hours of bed rest, Chen said. “There is no question patients prefer this,” Chen explained.

With patients who have undergone both radial and femoral access procedures, Chen said the vast majority will never let him touch their legs again. This type of patient satisfaction has spread by word of mouth and has led to an increasing number of patients seeking radial access procedures at St. Joseph’s. “My patients are the procedure’s and my best advocates,” Chen said.

In March 2010, St. Joseph's Hospital of Atlanta opened the first transradial access recover lounge in the United States. It replaces beds with chairs and patients are encouraged to walk around, get coffee, check their e-mail and read.

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init